ISSN: 2705-2214
Model: Open Access/Peer Reviewed
DOI: 10.31248/JPHD
Start Year: 2018
Email: jphd@integrityresjournals.org
https://doi.org/10.31248/JPHD2018.011 | Article Number: A92480D72 | Vol.1 (2) - October 2018
Received Date: 07 August 2018 | Accepted Date: 31 August 2018 | Published Date: 30 October 2018
Authors: Ajanya, B. U. , Attah F. , Mahmud M. E. , Owolabi B. I. , Adetoro, R. O. , Adeniyi, K. A.* and Oyibo-Usman, K. A.
Keywords: probiotics, potency, Chemotherapeutic, intestinal parasites, therapeutic.
Current World Health Organization estimates suggest that around 1.5 billion people worldwide and approximately a quarter of all people on earth, chiefly among the developing countries, are affected by intestinal parasites, despite the aggressive control and an alarming treatment over the years. Besides, the extensive use of the available chemotherapeutic agents, against the infection, has created widespread drug resistance problem. Probiotics, therapeutic non-pathogenic microorganisms have been recently identified as a novel alternative prophylactic and chemotherapeutic agents against several gastrointestinal parasites. They are mostly gram-positive bacteria, isolated from the human gut microflora or various dairy products such as curds, lassi and kulfi with characteristics non-pathogenic, resistant to low pH and acid. Their non-pathogenic symbiotic activities in the gut help in the restoration of gut bacteria microbiota by stimulating immune system, metabolism and anti-pathogenic effect, especially when administered in large quantity. In addition, several strains of probiotics have been identified to possess antiparasitic effects against some gastrointestinal parasites both in egg and larval stage of the parasites. This present review therefore elucidates the potential of probiotics in the treatment and management of gastrointestinal parasites. There is need for more clinical studies and especially molecular studies for better perception of the mechanism underlying the beneficial effects of probiotics on parasitic infections.
Abadi, A. R. (2018). Probiotics for the control of helminth zoonosis. Journal of Verterinary Medicine, 2018, 9p. | ||||
Abdel-Salam, A. M., Ammar, N., & Abdel-Hamid, A. Z. (2008). Effectiveness of probiotic labneh supplemented with garlic or onion oil against Schistosoma mansoni in infected mice. International Journal of Dairy Science, 3(2), 97-104. Crossref |
||||
Alak, J. I., Wolf, B. W., Mdurvwa, E. G., Pimentel-Smith, G. E., & Adeyemo, O. (1997). Effect of Lactobacillus reuteri on intestinal resistance to Cryptosporidium parvum infection in a Murine Model of Acquired Immunodeficiency Syndrome. The Journal of Infectious Diseases, 175, 218-221. Crossref |
||||
Alak, J. I., Wolf, B. W., Mdurvwa, E. G., Pimentel-Smith, G. E., Kolavala, S., Abdelrahman, H., & Suppiramaniam, V. (1999). Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of Cryptosporidium parvum Oocysts in Immunodeficient C57bl/6 Mice. Cellular and Molecular Biology, 45, 855-863. | ||||
Basualdo, J., Sparo, M., Chiodo, P., Ciarmela, M., & Minvielle, M. (2007). Oral treatment with a Potential Probiotic (Enterococcus faecalis Cect 7121). Appears to Reduce the Parasite Burden of mice infected with Toxocara canis. Annals of Tropical Medicine and Parasitology, 101, 559-562. Crossref |
||||
Bautista-Garfias, C. R., Ixta-Rodriguez, O., Martinez-Gomez, F., Lopez, M. G., & Aguilar-Figueroa, B. R. (2001). Effect of viable or dead Lactobacillus casei organisms administered orally to mice on resistance against Trichinella spiralis infection. Parasite, 8, 226-228. Crossref |
||||
Benyacoub, J., Perez, P. F., Rochat, F., Saudan, K. Y., Reuteler, G., Antille, N., Humen, M., De Antoni, G. L., Cavadini, C., Blum, S., & Schiffrin, E. J. (2005). Enterococcus faecium SF68 enhances the immune response to Giardia intestinalis in mice. The Journal of Nutrition, 135, 1171-1176. Crossref |
||||
Bratati, M., & Nirmal, K. G. (2014). The unexplored role of probiotics on the parasitic pathogens. Journal of Food and Nutrition Sciences, 5, 2177-2184. Crossref |
||||
Carlos, R. S, Luciana, P. V., Michele, R. S., Adriane, B. P. M., Caroline, T. Y., Juliano, D. L Ashok. P. & Vanete, T. S. (2010). The potential of probiotics: Review. Journal of Food Technology and Biotechnology, 48(4), 413-434. | ||||
Dalloul, R. A., Lillehoj, H. S., Shellem, T. A., & Doerr, J. A. (2003). Enhanced mucosal immunity against Eimeria acervulina in broilers fed a Lactobacillus-based probiotic. Poultry Science, 82, 62-66. Crossref |
||||
Dalloul, R. A., Lillehoj, H. S., Shellem, T. A., & Doerr, J. A. (2003). Intestinal immunomodulation by Vitamin A Defi- ciency and Lactobacillus-based probiotic in Eimeria acervulina-infected broiler chickens. Avian Diseases 47, 1313- 1320. Crossref |
||||
Dalloul, R. A., Lillehoj, H. S., Tamim, N. M., Shellem, T. A., & Doerr, J. A. (2005). Induction of local protective immunity to Eimeria acervulina by a Lactobacillus-based probiotic. Journal of Comparative Immunology, Microbiology and Infectious Diseases, 28, 351-361. Crossref |
||||
Dawson, H. D., Beshah, E., & Nishi, S. (2005). Localized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascarissuum. Infection and Immunity, 73, 1116–1128 Crossref |
||||
Deng, M., Nuanualsuwan, S., & Cliver, D. O. (2001). Inactivation of Cryptosporidium parvum Oocysts by Bacterial Strains. The Journal of Eukaryotic Microbiology 48, 37-39. Crossref |
||||
Elli, M., Zink, R., Rytz, A., Reniero, R., & Morelli, L. (2000). Iron requirement of Lactobacillus spp. in completely chemically defined growth media. Journal of Applied Microbiology, 88(4), 695–703. Crossref |
||||
Food and Agriculture Organization of the United Nations, World Health Organization (2002). Guidelines for the Evaluation of Probiotics in Food. Report of a joint FAO/WHO working Group on Drafting Guidelines for Evaluation of Probiotics in Food, London Ontario, Canada, Apr. 30 and May 1 http://who.int/foodsafety/fs_management/en/probiotic guidelines.pdf. | ||||
Foster, J. C., Glass, M. D., Courtney, P. D., & Ward, L. A. (2003). Effect of Lactobacillus and Bifidobacterium on Cryptosporidium parvum Oocyst viability. Food Microbiology, 20, 351-357. Crossref |
||||
Ghanem, K. Z., Abdel-Salam, A. M., & Magharby, A. S. (2005). Immunoprophylactic effect of probiotic yoghurt feeding on Schistosoma mansoni infected mice. Polish Journal of Food and Nutrition Science, 14, 123-126. | ||||
Glass, M. D., Courtney, P. D., LeJeune, J. T., & Ward, L. A. (2004). Effects of Lactobacillus acidophilus and Lactobacillus reuteri Cell-Free Supernatants on Cryptosporidium viability and infectivity in vitro. Food Microbiology, 21, 423-429. Crossref |
||||
Guarner, F., Khan, A.G., Garisch, J., Eliakim, R., Gangl, A., Thomson, A., Krabshuis, J., & Lemari, T. (2011). Prebiotics and Probiotics. World Gastroenterology Organisation Global Guidelines. 28, 1-28. | ||||
Guitard, J., Menotti, J., Desveaux, A., Alimardani, P., Porcher, R., Derouin, F., & Kapel, N. (2006). Experimental Study of the Effects of Probiotics on Cryptosporidium parvum Infection in Neonatal Rats. Parasitology Research, 99, 522-527. Crossref |
||||
Gupta, V., & Garg, R. (2009). Probiotics. Indian Journal of Medical Microbiology, 27(3), 202-209. Crossref |
||||
Harp, J. A., Jardon, P., Atwill, E. R., Zylstra, M., Checel, S., Goff, J. P. & De Simone, C. (1996). Field testing of pro-phylactic measures against Cryptosporidium parvum infection in calves in a California Dairy Herd. American Journal of Veterinary Research, 57, 1586-1588. | ||||
Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Canani, R. B., Flint, H. J., Salminen, S., & Calder, P. C. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology, 11(8), 506. Crossref |
||||
Humen, M. A., De Antoni, G. L., Benyacoub, J., Costas, M. E., Cardozo, M. I., Kozubsky, L., Saudan, K. Y., Boenzli- Bruand, A., Blum, S., Schiffrin, E. J., & Perez, P. F. (2005). Lactobacillus johnsonii La1 Antagonizes Giardia intestinalis in vivo. Infection and Immunity, 73, 1265-1269. Crossref |
||||
Kato, I., Tanaka, K., & Yokokura, T. (1999). Lactic Acid Bacterium Potently Induces the Production of Interleukin-12 and Interferon-Gamma by Mouse Splenocytes. International Journal of Immunopharmacology, 21, 121-131. Crossref |
||||
Lee, S. H., Lillehoj, H. S., Dalloul, R. A., Park, D. W., Hong, Y. H. & Lin, J. J. (2007). Influence of Pediococcus-based probiotic on Coccidiosis in broiler chickens. Poultry Science, 86, 63-66. Crossref |
||||
Lee, S., Lillehoj, H. S., Park, D. W., Hong, Y. H. & Lin, J. J. (2007). Effects of Pediococcus- and Saccharomyces-based probiotic on Coccidiosis in broiler chickens. Journal of Comparative Immunology, Microbiology and Infectious Diseases, 30, 261-268. Crossref |
||||
Luis, V. E., Tali, S., Tessa, N., Isabelle, I. & Sean, H. (2016). Modulating the gut micro-environment in the treatment of intestinal parasites, Journal of Clinical Medicine, 5, 102. Crossref |
||||
Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K., & Shafaghi, A. (2003) Efficacy of Saccharomyces boulardii with antibiotics in acute Amoebiasis. World Journal of Gastroenterology, 9, 1832-1833. Crossref |
||||
Marie-Agnes, T., Isabelle, F., Linda, K., & Philippe, G. (2011). Probiotics for the control of parasites: An overview. Journal of Parasitology Research, Pp. 1-11. | ||||
Martin, R., Miquel, S., Ulmer, J., Langella, P., & Bermudez-Humaran, L. G. (2014). Gut ecosystem: How microbes help us. Beneficial Microbes, 5, 219-233. Crossref |
||||
McClemens, J., Kim, J. J., Wang, H., Mao, Y. K., Collins, M., Kunze, W., Bienenstock, J., Forsythe, P., & Khan, W. I. (2013). Lactobacillus rhamnosus ingestion promotes innate host defense in an enteric parasitic infection. Clinical and Vaccine Immunology, 20, 818-826. Crossref |
||||
Mohammed, A. H., Osman, G. Y., Zowail, M. E. M., & El-Esawy, H. M. I. (2016). Effect of Lactobacillus sporogenes (probiotic) on certain parasitological and molecular aspects in Schistosoma mansoni infected mice. Journal of Parasitic Diseases, 40(3), 823-832. Crossref |
||||
Morelli, L., & Capurso, L. (2012). FAO/WHO Guidelines on Probiotics: 10 years later. Journal of Clinical Gastroenterology, 46(6), 1-2. Crossref |
||||
Mukhopadhyay, B., & Ganguly, N. K. (2014). The Unexplored Role of Probiotics on the parasitic pathogens. Food and Nutrition Sciences, 5, 2177-2184. Crossref |
||||
Muraro, A., Werfel, T., Hoffmann-Sommergruber, K., Roberts, G., Beyer, K., & Cardona, V. (2014). EAACI Food Allergy and Anaphylaxis Guidelines Group. EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy, 69(5), 590-601 Crossref |
||||
Nathan, G. (2018). Probiotic potential: Specific gut microbes could cause severity of parasitic infections in developing countries. Microbes, Pp. 1-3. | ||||
Obendorf, J., Renner Viveros, P., Fehlings, M., Klotz, C., Aebischer, T., & Ignatius, R. (2013) Increased Expression of CD25, CD83, and CD86, and Secretion of Il-12, Il-23, and Il-10 By Human Dendritic Cells Incubated in the Presence of Toll-Like Receptor 2 Ligands and Giardia duodenalis. Parasites & Vectors, 6, 317. Crossref |
||||
Obiukwu, M. O., Umeanaeto, P. U., Eneanya, C. I., & Nworgu, G. O. (2008). Prevalence of gastro-intestinal helminth in school children in Mbaukwu, Anambra State, Nigeria. Annals of Tropical Medicine and Parasitology, 101(8), 705-713. | ||||
Oelschlaeger, T. A. (2010). Mechanisms of probiotic actions-a review. International Journal of Medical Microbiology, 300, 57-62. Crossref |
||||
Opara, K. N., Nsima, I. U., Dominic, C. O., Okpok, E. O., Evelyn, U. E. & Anietie, J. U. (2012). The Impact of Intestinal Parasitic Infections on the Nutritional Status of Rural and Urban School-Aged Children in Nigeria. International Journal of MCH and AIDS. 1(1), 73-82. Crossref |
||||
Perez, P. F., Minnaard, J., Rouvet, M., Knabenhans, C., Brassart, D., De Antoni, G. L., & Schiffrin, E. J. (2001). Inhibition of Giardia intestinalis by extracellular factors from Lactobacilli: An in vitro study. Applied and Environmental Microbiology, 67, 5037-5042. Crossref |
||||
Pflughoeft, K., & Versalovic, J., (2012). Human microbiome in health and disease. Annual Review of Pathology, 7, 99-122.4. Crossref |
||||
Pickerd, N., & Tuthill, D. (2004). Resolution of Cryptosporidiosis with Probiotic Treatment. Postgraduate Medical Journal, 80, 112-113. Crossref |
||||
Santos, J. D. F. M., Vasconcelos, J., Souza, J. R. D., Coutinho, E. D. M., Montenegro, S. M. L., & Azevedo-Ximenes, E. (2004). The effect of Zymomonas mobilis culture on experimental Schistosoma mansoni infection. Revista da Sociedade Brasileira de Medicina Tropical, 37(6), 502-504. Crossref |
||||
Shukla, G., & Sidhu, R. K. (2011). Lactobacillus casei as a Probiotic in Malnourished Giardia lamblia-Infected Mice: A Biochemical and Histopathological Study. Canadian Journal of Microbiology, 57, 127-135. Crossref |
||||
Shukla, G., Devi, P., & Sehgal, R. (2008). Effect of Lactobacillus casei as a probiotic on modulation of Giardiasis. Digestive Diseases and Sciences, 53, 2671-2679. Crossref |
||||
Sirin, M., & Aziz, K. (2017). Role of probiotics in gastrointestinal diseases. EC Gastroenterology and Digestive System, 4(3), 94-100. | ||||
Solano-Aguilar, G., Shea-Donohue, T., Madden, K., Dawson, H., Ledbetter, T., Urban, J. J., & Gasbarre, L. C. (eds.) (2004) The Effect of Human-Derived Probiotic Bacteria on the Intestinal Function of Pigs. (Veterinary Parasitology), Symposium: New Approaches in the Study of Animal Parasites, 125, 147-161. | ||||
Szajewska, H., Guarino, A., Hojsak, I., Indrio, F., Kolacek, S., Shamir, R., Vandenplas, Y., & Weizman, z., (2014). Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. Journal of Pediatric Gastroenterology and Nutrition 58(4), 531-539. Crossref |
||||
Tierney, J., Gowing, H., Van Sinderen, D., Flynn, S., Stanley, L., McHardy, N., Hallahan, S., & Mulcahy, G. (2004). In vitro inhibition of Eimeria tenella invasion by indigenous chicken Lactobacillus species. Veterinary Parasitology, 122, 171-182. Crossref |
||||
Torgerson, P. R., & Macpherson, C. N. (2011). The socioeconomic burden of parasitic zoonoses: global trends. Veterinary Parasitology, 182(1), 79-95. Crossref |
||||
Travers, M. A., Florent, I., Kohl, L., & Grellier, P. (2011). Probiotics for the control of parasites: An overview. Journal of Parasitology Research, 2011, 11p. Crossref |
||||
Urbańska, M., & Szajewska, H. (2014). The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. European Journal of Pediatrics, 173(10), 1327-1337. Crossref |
||||
Vasconcelos, J. de F’atima, J. de Souza, J. R. de Medeiros, C. E, Montenegro, S. M. L., & Azevedo, E. (2004). The effect of Zymomonasmobilis culture on experimental Schistosomamansoni infection. Revista da SociedadeBrasileira de Medicina Tropical, 37, 502-504. Crossref |
||||
Vincent, M. (2003). Parasites in the gastrointestinal tract. Journal of parasite Immunology, 25, 231-234. Crossref |
||||
Waters, W. R., Harp, J. A., Wannemuehler, M. J., Carbajal, N. Y., & Casas, I. A. (1999). Effects of Lactobacillus reuteri on Cryptosporidium parvum Infection of Gnotobiotic Tcr-Alpha-Deficient Mice. The Journal of Eukaryotic Microbiology, 46, 60-61. | ||||
Wohlgemuth, S., Loh, G., & Blaut, M. (2010). Recent developments and perspectives in the investigation of probiotic effects. International Journal of Medical Microbiology, 300(1), 3-10. Crossref |
||||
Zowail, M. E. M., Osman, G. Y., Mohamed, A. H., & El-Esawy, H. M. I. (2012). Protective role of Lactobacillus sporogenes (probiotic) on chromosomal aberrations and DNA fragmentation in Schistosoma mansoni infected mice. Egyptian Journal of Experimental Biology (Zoology), 8, 121-130. |